Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables | Journal of Molecular Histology |
| 13 | 2014 |
CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer | Oncology Reports |
| 27 | 2014 |
Immunohistochemical localization of translationally controlled tumor protein in the mouse digestive system | Journal of Anatomy |
| 6 | 2013 |
Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity | Toxicology Letters |
| 75 | 2013 |
TCTP overexpression is associated with the development and progression of glioma | Tumor Biology |
| 29 | 2013 |
Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy | Cancer Drug Resistance |
| 2023 | |
Prognostic value of translationally controlled tumor protein in colon cancer | Molecular and Clinical Oncology |
| 2023 | |
Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes | Nature Communications |
| 6 | 2022 |
Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects | Journal of Zhejiang University-SCIENCE B |
| 2022 | |
A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy | Investigational New Drugs |
| 6 | 2021 |